A Workflow Combining Machine Learning with Molecular Simulations Uncovers Potential Dual-Target Inhibitors against BTK and JAK3
Open Access
Abstract
The drug development process suffers from low success rates and requires expensive and time-consuming procedures. The traditional one drug–one target paradigm is often inadequate to treat multifactorial diseases. Multitarget drugs may potentially address problems such as adverse reactions to drugs. With the aim to discover a multitarget potential inhibitor for B-cell lymphoma treatment, herein, we developed a general pipeline combining machine learning, the interpretable model SHapley Additive exPlanation (SHAP), and molecular dynamics simulations to predict active compounds and fragments. Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3) are popular synergistic targets for B-cell lymphoma. We used this pipeline approach to identify prospective potential dual inhibitors from a natural product database and screened three candidate inhibitors with acceptable drug absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Ultimately, the compound CNP0266747 with specialized binding conformations that exhibited potential binding free energy against BTK and JAK3 was selected as the optimum choice. Furthermore, we also identified key residues and fingerprint features of this dual-target inhibitor of BTK and JAK3.Keywords
Funding Information
- National Science Center (NCN), Poland (UMO-2020/39/B/ST8/02937, 8217121063)
- National Natural Science Foundation of China (NSFC) (UMO-2020/39/B/ST8/02937, 8217121063)
This publication has 55 references indexed in Scilit:
- The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironmentBlood, 2010
- Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsetsBritish Journal of Haematology, 2010
- Extended-Connectivity FingerprintsJournal of Chemical Information and Modeling, 2010
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domainImmunological Reviews, 2009
- Performance of B3LYP Density Functional Methods for a Large Set of Organic MoleculesJournal of Chemical Theory and Computation, 2008
- A semiempirical free energy force field with charge‐based desolvationJournal of Computational Chemistry, 2007
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Signalling of Bruton's Tyrosine Kinase, BtkScandinavian Journal of Immunology, 1999
- Bayesian Methods for Modeling Recovery Times with an Application to the Loss of Off‐Site Power at Nuclear Power PlantsRisk Analysis, 1989